Prior Authorization for Antidepressants in Medicaid | Zendy

Alyce S. Adams | Zendy; Fang Zhang | Zendy; Robert F. LeCates | Zendy; Amy J. Graves | Zendy; Dennis RossDegnan | Zendy; Daniel Gilden | Zendy; Thomas J. McLaughlin | Zendy; Christine Y. Lu | Zendy; Connie Mah Trinacty | Zendy; Stephen B. Soumerai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prior Authorization for Antidepressants in Medicaid

Author(s) -

Alyce S. Adams,

Fang Zhang,

Robert F. LeCates,

Amy J. Graves,

Dennis RossDegnan,

Daniel Gilden,

Thomas J. McLaughlin,

Christine Y. Lu,

Connie Mah Trinacty,

Stephen B. Soumerai

Publication year - 2009

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2009.39

Subject(s) - medicaid , prior authorization , medicine , adverse effect , depression (economics) , authorization , population , emergency department , emergency medicine , medicare advantage , demography , family medicine , psychiatry , health care , environmental health , nursing , computer security , sociology , computer science , economics , macroeconomics , economic growth

Prior authorization is a popular, but understudied, strategy for reducing medication costs. We evaluated the impact of a controversial prior authorization policy in Michigan Medicaid on antidepressant use and health outcomes among dual Medicaid and Medicare enrollees with a Social Security Disability Insurance designation of permanent disability.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research